Ligand ID: X6X Drugbank ID: DB01296(Glucosamine) Indication:Glucosamine is usually used in the treatment of osteoarthritis, although its efficacy is still in question. |
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
---|---|---|---|---|---|---|---|---|---|---|
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 2dd8 | IGG HEAVY CHAIN (Homosapiens) | 4 / 8 | GLY H 49GLY H 50VAL H 37ASP H 95 | 1.37A | 19.57 | None | ||
![]() | 5F8Y_A_X6XA201_1 (GALNAC/GAL-SPECIFICLECTIN) | 2gdt | NSP1 (EC 3.4.22.-) P65 HOMOLOGLEADER PROTEIN (SARSr) | 5 / 9 | HIS A 70GLY A 71GLY A 71HIS A 70ASP A 64 | 1.39A | 17.68 | None | ||
![]() | 5F8Y_A_X6XA201_1 (GALNAC/GAL-SPECIFICLECTIN) | 2gdt | NSP1 (EC 3.4.22.-) P65 HOMOLOGLEADER PROTEIN (SARSr) | 5 / 9 | ASN A 69HIS A 72GLY A 71GLY A 71VAL A 74 | 1.41A | 17.68 | None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 2gdt | NSP1 (EC 3.4.22.-) P65 HOMOLOGLEADER PROTEIN (SARSr) | 4 / 8 | GLY A 116GLY A 116VAL A 3HIS A 2 | 0.88A | 17.68 | None | ||
![]() | 5F8Y_A_X6XA201_1 (GALNAC/GAL-SPECIFICLECTIN) | 2gdt | NSP1 (EC 3.4.22.-) P65 HOMOLOGLEADER PROTEIN (SARSr) | 5 / 9 | ASN A 69GLY A 71GLY A 71VAL A 74HIS A 70 | 1.47A | 17.68 | None | ||
![]() | 5F8Y_A_X6XA201_1 (GALNAC/GAL-SPECIFICLECTIN) | 2gdt | NSP1 (EC 3.4.22.-) P65 HOMOLOGLEADER PROTEIN (SARSr) | 5 / 9 | HIS A 70GLY A 71GLY A 71HIS A 70HIS A 72 | 1.23A | 17.68 | None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 2gdt | NSP1 (EC 3.4.22.-) P65 HOMOLOGLEADER PROTEIN (SARSr) | 4 / 8 | HIS A 72GLY A 71GLY A 71VAL A 74 | 1.04A | 17.68 | None | ||
![]() | 5F8Y_A_X6XA201_1 (GALNAC/GAL-SPECIFICLECTIN) | 2gdt | NSP1 (EC 3.4.22.-) P65 HOMOLOGLEADER PROTEIN (SARSr) | 5 / 9 | ASN A 69HIS A 70GLY A 71GLY A 71HIS A 70 | 1.12A | 17.68 | None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 2gdt | LEADER PROTEIN P65 HOMOLOG NSP1 (SARSr-CoV) | 4 / 8 | GLU A 30GLY A 21GLY A 19HIS A 34 | 1.35A | 17.68 | None | ||
![]() | 5F8Y_A_X6XA201_1 (GALNAC/GAL-SPECIFICLECTIN) | 2gdt | NSP1 (EC 3.4.22.-) P65 HOMOLOGLEADER PROTEIN (SARSr) | 5 / 9 | ASN A 115HIS A 2GLY A 1GLY A 1HIS A 70 | 1.28A | 17.68 | None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 2gdt | NSP1 (EC 3.4.22.-) P65 HOMOLOGLEADER PROTEIN (SARSr) | 4 / 8 | GLY A 1GLY A 1VAL A 74HIS A 72 | 0.98A | 17.68 | None | ||
![]() | 5F8Y_A_X6XA201_1 (GALNAC/GAL-SPECIFICLECTIN) | 2gdt | NSP1 (EC 3.4.22.-) P65 HOMOLOGLEADER PROTEIN (SARSr) | 5 / 9 | HIS A 70GLY A 1GLY A 1HIS A 70HIS A 72 | 1.35A | 17.68 | None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 2gdt | NSP1 (EC 3.4.22.-) P65 HOMOLOGLEADER PROTEIN (SARSr) | 4 / 8 | GLY A 71GLY A 71VAL A 74HIS A 70 | 1.05A | 17.68 | None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 2gdt | NSP1 (EC 3.4.22.-) P65 HOMOLOGLEADER PROTEIN (SARSr) | 4 / 8 | HIS A 70GLY A 71GLY A 71HIS A 70 | 0.79A | 17.68 | None | ||
![]() | 5F8Y_A_X6XA201_1 (GALNAC/GAL-SPECIFICLECTIN) | 2gdt | NSP1 (EC 3.4.22.-) P65 HOMOLOGLEADER PROTEIN (SARSr) | 5 / 9 | HIS A 70GLY A 1GLY A 71HIS A 70HIS A 72 | 1.45A | 17.68 | None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 2gdt | NSP1 (EC 3.4.22.-) P65 HOMOLOGLEADER PROTEIN (SARSr) | 4 / 8 | HIS A 70GLY A 71HIS A 70HIS A 72 | 1.03A | 17.68 | None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 2gtb | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 8 | HIS A 41VAL A 42ASP A 187HIS A 164 | 1.33A | 15.86 | AZP A 401 (-3.4A)NoneNoneNone | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 2h85 | PUTATIVE ORF1ABPOLYPROTEIN (SARSr-CoV) | 4 / 8 | HIS A 249GLY A 238VAL A 294HIS A 234 | 1.36A | 17.35 | None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 2ozk | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 4 / 8 | HIS D 234GLY D 246GLY D 247HIS D 249 | 1.33A | 17.40 | None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 2xyq | PUTATIVE 2'-O-METHYLTRANSFERASE (SARSr-CoV) | 4 / 8 | GLY A 81VAL A 78ASP A 97HIS A 69 | 1.14A | 17.53 | SAH A1293 (-3.6A)NoneNoneNone | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 2xyr | PUTATIVE 2'-O-METHYLTRANSFERASE (SARSr-CoV) | 4 / 8 | GLY A 81VAL A 78ASP A 97HIS A 69 | 1.14A | 18.09 | SFG A1298 (-3.5A)NoneNoneNone | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 3d0i | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 4 / 8 | GLY A 561GLY A 395ASP A 382HIS A 401 | 1.33A | 13.77 | None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 3iwm | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 8 | HIS D 41VAL D 42ASP D 187HIS D 164 | 1.29A | 16.83 | None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 3r24 | 2'-O-METHYLTRANSFERASE (SARSr-CoV) | 4 / 8 | GLY A 81VAL A 78ASP A 97HIS A 69 | 1.13A | 16.23 | SAM A 302 (-3.4A)NoneNoneNone | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 3sck | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 4 / 8 | HIS B 401GLY B 395VAL B 404ASP B 350 | 1.26A | 13.41 | None | ||
![]() | 5BR1_A_X6XA401_1 (ABC TRANSPORTER,BINDING PROTEIN) | 3scl | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 11 | ARG B 219ASP B 201TYR B 202HIS B 195ASN B 194 | 1.63A | 20.86 | None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 4rna | PAPAIN-LIKE PROTEASE (Humanbetacoronavirus2cEMC/2012) | 4 / 8 | GLY A 248GLY A 211VAL A 310ASP A 217 | 1.27A | 17.13 | NoneNonePO4 A 404 ( 4.5A)None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 5c8s | GUANINE-N7METHYLTRANSFERASENSP10 (SARSr-CoV) | 4 / 8 | HIS B 19GLY A 70GLY A 69ASP B 41 | 1.37A | 13.39 | None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 5c8u | GUANINE-N7METHYLTRANSFERASE (SARSr-CoV) | 4 / 8 | HIS B 264GLY B 417GLY B 413VAL B 263 | 1.30A | 13.56 | ZN B 602 (-2.5A)NoneNoneNone | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 5c8u | GUANINE-N7METHYLTRANSFERASENSP10 (SARSr-CoV) | 4 / 8 | GLY C 70GLY C 69HIS D 19ASP D 41 | 1.07A | 24.54 | None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 5nfy | POLYPROTEIN 1AB (SARS-COVFrankfurt1) | 4 / 8 | HIS D 264GLY D 417GLY D 413VAL D 263 | 1.19A | 13.60 | ZN D 602 (-3.2A)NoneNoneNone | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 5nfy | POLYPROTEIN 1AB (SARS-COVFrankfurt1) | 4 / 8 | GLY P 70GLY P 69HIS C 19ASP C 41 | 1.18A | 25.45 | None | ||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 8 | GLY A 146VAL A 114HIS A 163HIS A 164 | 1.54A | 18.82 | None | ||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 8 | GLY A 29GLY A 146VAL A 42HIS A 164 | 1.79A | 18.82 | None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 8 | GLY A 146VAL A 114HIS A 163HIS A 164 | 1.52A | 18.82 | None | ||
![]() | 5F8Y_A_X6XA201_1 (GALNAC/GAL-SPECIFICLECTIN) | 5wrg | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 9 | HIS A1030TYR A1029GLY A1028GLY A1026HIS A1046 | 1.51A | 7.04 | None | ||
![]() | 5F8Y_A_X6XA203_1 (GALNAC/GAL-SPECIFICLECTIN) | 5wrg | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 9 | HIS A1030TYR A1029GLY A1028GLY A1026HIS A1046 | 1.49A | 7.04 | None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 5x5b | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 4 / 8 | GLY A 873GLY A 871VAL C1050ASP C1023 | 1.19A | 7.17 | None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 5xlr | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 8 | HIS A1030GLY A1028GLY A1026HIS A1046 | 1.26A | 7.04 | HIS A1030 ( 1.0A)GLY A1028 ( 0.0A)GLY A1026 ( 0.0A)HIS A1046 ( 1.0A) | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6acd | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 8 | HIS C1030GLY C1028GLY C1026HIS C1046 | 1.18A | 7.04 | None | ||
![]() | 5F8Y_A_X6XA201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6acd | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 9 | HIS C1030TYR C1029GLY C1028GLY C1026HIS C1046 | 1.44A | 7.04 | None | ||
![]() | 5F8Y_A_X6XA203_1 (GALNAC/GAL-SPECIFICLECTIN) | 6acd | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 9 | HIS C1030TYR C1029GLY C1028GLY C1026HIS C1046 | 1.43A | 7.04 | None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6acg | ACE2 (Homosapiens) | 4 / 8 | HIS D 401GLY D 395VAL D 404ASP D 350 | 1.01A | 13.43 | None | ||
![]() | 5F8Y_A_X6XA203_1 (GALNAC/GAL-SPECIFICLECTIN) | 6crz | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 9 | HIS B1030TYR B1029GLY B1028GLY B1026HIS B1046 | 1.56A | 7.16 | None | ||
![]() | 5F8Y_A_X6XA201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6cs0 | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 9 | HIS B1030TYR B1029GLY B1028GLY B1026HIS B1046 | 1.57A | 7.16 | None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6cs2 | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 4 / 8 | GLY B 873GLY B 871VAL A1050ASP A1023 | 1.12A | 7.16 | None | ||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6lze | VIRAL PROTEASE (SARS-CoV-2) | 4 / 8 | GLY A 146VAL A 114HIS A 163HIS A 164 | 1.60A | 17.00 | NoneNoneELL D 3 (-3.9A)None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6lze | VIRAL PROTEASE (SARS-CoV-2) | 4 / 8 | GLY A 146VAL A 114HIS A 163HIS A 164 | 1.58A | 17.00 | NoneNoneELL D 3 (-3.9A)None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6lzg | ACE2 (Homosapiens) | 4 / 8 | GLU A 435GLY A 537HIS A 540HIS A 535 | 1.32A | 13.79 | None | ||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m0k | VIRAL PROTEASE (SARS-CoV-2) | 4 / 8 | HIS A 41VAL A 42ASP A 187HIS A 164 | 1.44A | 16.94 | N0A D 2 ( 4.0A)NoneNoneNone | ||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m0k | VIRAL PROTEASE (SARS-CoV-2) | 4 / 8 | GLY A 146VAL A 114HIS A 163HIS A 164 | 1.57A | 16.94 | NoneNoneELL D 3 (-3.9A)None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m0k | VIRAL PROTEASE (SARS-CoV-2) | 4 / 8 | GLY A 146VAL A 114HIS A 163HIS A 164 | 1.56A | 16.94 | NoneNoneELL D 3 (-3.9A)None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m18 | ACE2 (Homosapiens) | 4 / 8 | HIS B 401GLY B 395VAL B 404ASP B 382 | 1.30A | 10.44 | None | ||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 8 | GLY C 146VAL C 114HIS C 163HIS C 164 | 1.59A | 16.83 | None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 8 | HIS A 41VAL A 42ASP A 187HIS A 164 | 1.45A | 16.83 | 3WL A 401 (-3.7A)NoneNoneNone | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 8 | GLY A 146VAL A 114HIS A 163HIS A 164 | 1.59A | 16.83 | None | ||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 8 | HIS B 41VAL B 42ASP B 187HIS B 164 | 1.69A | 16.83 | 3WL B 401 (-3.7A)NoneNoneNone | ||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 8 | GLY A 146VAL A 114HIS A 163HIS A 164 | 1.59A | 16.83 | None | ||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 8 | HIS A 41VAL A 42ASP A 187HIS A 164 | 1.43A | 16.83 | 3WL A 401 (-3.7A)NoneNoneNone | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 8 | GLY B 146VAL B 114HIS B 163HIS B 164 | 1.57A | 16.83 | None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 8 | GLY C 146VAL C 114HIS C 163HIS C 164 | 1.59A | 16.83 | None | ||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 8 | GLY B 146VAL B 114HIS B 163HIS B 164 | 1.57A | 16.83 | None | ||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m2q | 3CL PROTEASE (SARS-CoV-2) | 4 / 8 | GLY A 146VAL A 114HIS A 163HIS A 164 | 1.56A | 16.83 | None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m2q | 3CL PROTEASE (SARS-CoV-2) | 4 / 8 | GLY A 146VAL A 114HIS A 163HIS A 164 | 1.55A | 16.83 | None | ||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 8 | GLU A 665GLY A 678GLY A 679VAL A 667 | 1.58A | 10.72 | None | ||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 8 | GLY A 485GLY A 486HIS A 572HIS A 642 | 1.46A | 10.72 | None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 8 | HIS A 599GLY A 596GLY A 597VAL A 827 | 1.32A | 10.72 | None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 8 | GLU A 665GLY A 678GLY A 679VAL A 667 | 1.58A | 10.72 | None | ||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 8 | GLU A 665GLY A 679VAL A 667ASP A 684 | 1.63A | 10.72 | None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 8 | GLU A 665GLY A 679VAL A 667ASP A 684 | 1.63A | 10.72 | None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 8 | HIS A 572GLY A 485GLY A 486HIS A 642 | 1.42A | 10.72 | None | ||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 8 | HIS A 572GLY A 485GLY A 486HIS A 642 | 1.40A | 10.72 | None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 8 | GLY A 596GLY A 597VAL A 827HIS A 599 | 1.57A | 10.72 | None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 8 | GLY A 485GLY A 486HIS A 572HIS A 642 | 1.41A | 10.72 | None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6nb6 | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 8 | HIS C1030GLY C1028GLY C1026HIS C1046 | 1.23A | 7.44 | None | ||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6vxs | NSP3 (SARS-CoV-2) | 4 / 8 | HIS A 45GLY A 47GLY A 46VAL A 49 | 1.51A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6vxs | NSP3 (SARS-CoV-2) | 4 / 8 | GLY A 85VAL A 82HIS A 94HIS A 86 | 1.44A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6vxs | NSP3 (SARS-CoV-2) | 4 / 8 | GLY B 85VAL B 82HIS B 94HIS B 86 | 1.44A | NoneNHE B 203 (-4.9A)NoneNone | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6vxs | NSP3 (SARS-CoV-2) | 4 / 8 | HIS A 45GLY A 47GLY A 46VAL A 49 | 1.51A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6vxs | NSP3 (SARS-CoV-2) | 4 / 8 | GLY B 85VAL B 82HIS B 94HIS B 86 | 1.43A | NoneNHE B 203 (-4.9A)NoneNone | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6vxs | NSP3 (SARS-CoV-2) | 4 / 8 | HIS B 45GLY B 47GLY B 46VAL B 49 | 1.49A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6vxs | NSP3 (SARS-CoV-2) | 4 / 8 | HIS B 45GLY B 47GLY B 46VAL B 49 | 1.49A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6vxs | NSP3 (SARS-CoV-2) | 4 / 8 | GLY A 85VAL A 82HIS A 94HIS A 86 | 1.42A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6vyo | NUCLEOPROTEIN (SARS-CoV-2) | 4 / 8 | HIS B 59GLY B 60ASP C 82HIS C 145 | 1.30A | 23.03 | ZN C 201 ( 3.1A)None ZN C 201 ( 2.1A) ZN C 201 ( 3.2A) | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w4h | NSP16 (SARS-CoV-2) | 4 / 8 | GLY A6879VAL A6876ASP A6895HIS A6867 | 1.14A | 16.89 | SAM A7102 (-3.4A)NoneNoneNone | ||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | GLY A6879VAL A6876ASP A6895HIS A6867 | 1.20A | SAM A7104 (-3.6A)NoneNoneNone | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | GLY A6869VAL A6916ASP A6895HIS A6867 | 1.58A | SAM A7104 (-3.6A)NoneNoneNone | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | GLY A6879VAL A6876ASP A6895HIS A6867 | 1.13A | SAM A7104 (-3.6A)NoneNoneNone | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | GLY A6869VAL A6916ASP A6895HIS A6867 | 1.56A | SAM A7104 (-3.6A)NoneNoneNone | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 8 | HIS B 45GLY B 47GLY B 46VAL B 49 | 1.53A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 8 | HIS A 45GLY A 47GLY A 46VAL A 49 | 1.56A | NoneNoneNoneAMP A 201 ( 3.7A) | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 8 | HIS B 45GLY B 47GLY B 46VAL B 49 | 1.53A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 8 | GLY A 85VAL A 82HIS A 94HIS A 86 | 1.42A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 8 | HIS A 45GLY A 47GLY A 46VAL A 49 | 1.56A | NoneNoneNoneAMP A 201 ( 3.7A) | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 8 | GLY A 85VAL A 82HIS A 94HIS A 86 | 1.42A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 8 | GLY B 85VAL B 82HIS B 94HIS B 86 | 1.47A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 8 | GLY B 85VAL B 82HIS B 94HIS B 86 | 1.47A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 8 | GLY A6869VAL A6916ASP A6895HIS A6867 | 1.62A | 19.79 | SAM A7102 ( 3.8A)NoneNoneNone | ||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 8 | GLY C6869VAL C6916ASP C6895HIS C6867 | 1.62A | 19.79 | SAM C7105 ( 3.8A)NoneNoneNone | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 8 | GLY C6869VAL C6916ASP C6895HIS C6867 | 1.59A | 19.79 | SAM C7105 ( 3.8A)NoneNoneNone | ||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 8 | GLY A6879VAL A6876ASP A6895HIS A6867 | 1.23A | 19.79 | SAM A7102 ( 3.4A)NoneNoneNone | ||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 8 | GLY C6879VAL C6876ASP C6895HIS C6867 | 1.22A | 19.79 | SAM C7105 ( 3.4A)NoneNoneNone | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 8 | GLY A6879VAL A6876ASP A6895HIS A6867 | 1.16A | 19.79 | SAM A7102 ( 3.4A)NoneNoneNone | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 8 | GLY C6879VAL C6876ASP C6895HIS C6867 | 1.15A | 19.79 | SAM C7105 ( 3.4A)NoneNoneNone | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 8 | GLY A6869VAL A6916ASP A6895HIS A6867 | 1.60A | 19.79 | SAM A7102 ( 3.8A)NoneNoneNone | ||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 4 / 8 | GLU C 51HIS C 50VAL C 7HIS C 47 | 1.68A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 4 / 8 | GLU B 263HIS B 272GLY B 266GLY B 271 | 1.43A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 4 / 8 | GLU B 263HIS B 272GLY B 266GLY B 271 | 1.43A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 4 / 8 | GLU C 51HIS C 50VAL C 7HIS C 47 | 1.66A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wcf | NSP3 (SARS-CoV-2) | 4 / 8 | GLY A 85VAL A 82HIS A 94HIS A 86 | 1.48A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wcf | NSP3 (SARS-CoV-2) | 4 / 8 | HIS A 45GLY A 47GLY A 46VAL A 49 | 1.53A | NoneMES A 202 (-3.4A)MES A 202 (-4.7A)None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wcf | NSP3 (SARS-CoV-2) | 4 / 8 | HIS A 45GLY A 47GLY A 46VAL A 49 | 1.53A | NoneMES A 202 (-3.4A)MES A 202 (-4.7A)None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wcf | NSP3 (SARS-CoV-2) | 4 / 8 | GLY A 85VAL A 82HIS A 94HIS A 86 | 1.48A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wen | NSP3 (SARS-CoV-2) | 4 / 8 | GLY A 85VAL A 82HIS A 94HIS A 86 | 1.40A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wen | NSP3 (SARS-CoV-2) | 4 / 8 | HIS A 45GLY A 47GLY A 46VAL A 49 | 1.46A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wen | NSP3 (SARS-CoV-2) | 4 / 8 | GLY A 47GLY A 46VAL A 49HIS A 45 | 1.67A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wen | NSP3 (SARS-CoV-2) | 4 / 8 | GLY A 85VAL A 82HIS A 94HIS A 86 | 1.40A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wen | NSP3 (SARS-CoV-2) | 4 / 8 | HIS A 45GLY A 47GLY A 46VAL A 49 | 1.47A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wey | NSP3 (SARS-CoV-2) | 4 / 8 | HIS A 249GLY A 251GLY A 250VAL A 253 | 1.59A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wey | NSP3 (SARS-CoV-2) | 4 / 8 | GLY A 289VAL A 286HIS A 298HIS A 290 | 1.44A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wey | NSP3 (SARS-CoV-2) | 4 / 8 | GLY A 289VAL A 286HIS A 298HIS A 290 | 1.44A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wey | NSP3 (SARS-CoV-2) | 4 / 8 | HIS A 249GLY A 251GLY A 250VAL A 253 | 1.60A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | GLY C6869VAL C6916ASP C6895HIS C6867 | 1.64A | SAH C7102 (-3.8A)NoneNoneNone | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | GLY A6869VAL A6916ASP A6895HIS A6867 | 1.58A | SAH A7102 (-3.8A)NoneNoneNone | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | GLY A6879VAL A6876ASP A6895HIS A6867 | 1.23A | SAH A7102 (-3.5A)NoneNoneNone | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | GLY A6869VAL A6916ASP A6895HIS A6867 | 1.61A | SAH A7102 (-3.8A)NoneNoneNone | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | GLY C6879VAL C6876ASP C6895HIS C6867 | 1.16A | SAH C7102 (-3.5A)NoneNoneNone | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | GLY C6879VAL C6876ASP C6895HIS C6867 | 1.22A | SAH C7102 (-3.5A)NoneNoneNone | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | GLY C6869VAL C6916ASP C6895HIS C6867 | 1.61A | SAH C7102 (-3.8A)NoneNoneNone | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | GLY A6879VAL A6876ASP A6895HIS A6867 | 1.17A | SAH A7102 (-3.5A)NoneNoneNone | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wkp | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 4 / 8 | HIS B 145GLY A 60HIS A 59ASP B 82 | 1.68A | ZN B 202 (-3.3A)None ZN B 202 (-2.6A) ZN B 202 (-2.3A) | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wkq | NSP16 (SARS-CoV-2) | 4 / 8 | GLY C6869VAL C6916ASP C6895HIS C6867 | 1.62A | SFG C7103 ( 3.7A)NoneNoneNone | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wkq | NSP16 (SARS-CoV-2) | 4 / 8 | GLY A6869VAL A6916ASP A6895HIS A6867 | 1.61A | SFG A7103 ( 3.8A)NoneNoneNone | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wkq | NSP16 (SARS-CoV-2) | 4 / 8 | GLY C6879VAL C6876ASP C6895HIS C6867 | 1.15A | SFG C7103 ( 3.5A)NoneNoneNone | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wkq | NSP16 (SARS-CoV-2) | 4 / 8 | GLY C6879VAL C6876ASP C6895HIS C6867 | 1.22A | SFG C7103 ( 3.5A)NoneNoneNone | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wkq | NSP16 (SARS-CoV-2) | 4 / 8 | GLY A6879VAL A6876ASP A6895HIS A6867 | 1.17A | SFG A7103 ( 3.5A)NoneNoneNone | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wkq | NSP16 (SARS-CoV-2) | 4 / 8 | GLY A6879VAL A6876ASP A6895HIS A6867 | 1.23A | SFG A7103 ( 3.5A)NoneNoneNone | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wkq | NSP16 (SARS-CoV-2) | 4 / 8 | GLY A6869VAL A6916ASP A6895HIS A6867 | 1.58A | SFG A7103 ( 3.8A)NoneNoneNone | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wkq | NSP16 (SARS-CoV-2) | 4 / 8 | GLY C6869VAL C6916ASP C6895HIS C6867 | 1.59A | SFG C7103 ( 3.7A)NoneNoneNone | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 4 / 8 | HIS A 250GLY A 239VAL A 295HIS A 235 | 1.41A | U5P A 401 (-4.1A)NoneNoneNone | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 4 / 8 | HIS B 250GLY B 239VAL B 295HIS B 235 | 1.38A | U5P B 401 (-4.1A)NoneNoneNone | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 4 / 8 | HIS A 250GLY A 239VAL A 295HIS A 235 | 1.43A | U5P A 401 (-4.1A)NoneNoneNone | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 4 / 8 | HIS B 250GLY B 239VAL B 295HIS B 235 | 1.40A | U5P B 401 (-4.1A)NoneNoneNone | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wnp | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 8 | GLY A 146VAL A 114HIS A 163HIS A 164 | 1.58A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wnp | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 8 | HIS A 41VAL A 42ASP A 187HIS A 164 | 1.42A | U5G A 401 (-3.3A)NoneNoneNone | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wnp | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 8 | GLY A 146VAL A 114HIS A 163HIS A 164 | 1.57A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | GLY B 85VAL B 82HIS B 94HIS B 86 | 1.42A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | GLY A 85VAL A 82HIS A 94HIS A 86 | 1.47A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | GLY A 85VAL A 82HIS A 94HIS A 86 | 1.46A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | HIS A 45GLY A 47GLY A 46VAL A 49 | 1.65A | NoneAPR A 201 (-4.1A)APR A 201 (-3.9A)APR A 201 (-3.8A) | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | GLY B 85VAL B 82HIS B 94HIS B 86 | 1.41A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | HIS D 45GLY D 47GLY D 46VAL D 49 | 1.69A | NoneAPR D 201 (-4.2A)APR D 201 (-3.8A)APR D 201 (-3.6A) | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | GLY D 85VAL D 82HIS D 94HIS D 86 | 1.40A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | HIS C 45GLY C 47GLY C 46VAL C 49 | 1.65A | NoneAPR C 201 (-4.1A)APR C 201 (-3.9A)APR C 201 (-3.8A) | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | HIS C 45GLY C 47GLY C 46VAL C 49 | 1.63A | NoneAPR C 201 (-4.1A)APR C 201 (-3.9A)APR C 201 (-3.8A) | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | GLY A 103VAL A 77ASP B 135HIS B 138 | 1.55A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | GLY C 85VAL C 82HIS C 94HIS C 86 | 1.41A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | GLY A 103VAL A 77ASP B 135HIS B 138 | 1.51A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | GLY C 85VAL C 82HIS C 94HIS C 86 | 1.40A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | HIS B 45GLY B 47GLY B 46VAL B 49 | 1.68A | NoneAPR B 201 (-4.0A)APR B 201 (-3.7A)APR B 201 (-3.7A) | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | GLY D 85VAL D 82HIS D 94HIS D 86 | 1.39A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wq3 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | GLY A6879VAL A6876ASP A6895HIS A6867 | 1.21A | SAH A7101 (-3.5A)NoneNoneNone | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wq3 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | GLY A6869VAL A6916ASP A6895HIS A6867 | 1.61A | SAH A7101 (-3.8A)NoneNoneNone | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wq3 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | GLY A6879VAL A6876ASP A6895HIS A6867 | 1.15A | SAH A7101 (-3.5A)NoneNoneNone | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wq3 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | GLY A6869VAL A6916ASP A6895HIS A6867 | 1.58A | SAH A7101 (-3.8A)NoneNoneNone | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wqf | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 8 | HIS A 41VAL A 42ASP A 187HIS A 164 | 1.42A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6wqf | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 8 | GLY A 146VAL A 114HIS A 163HIS A 164 | 1.60A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6y2g | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | HIS B 41VAL B 42ASP B 187HIS B 164 | 1.34A | 16.83 | O6K B 401 ( 3.7A)NoneNoneNone | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | GLY A 146VAL A 114HIS A 163HIS A 164 | 1.53A | 18.60 | NoneNoneDMS A 405 (-3.9A)None | ||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | GLY A 29GLY A 146VAL A 42HIS A 164 | 1.79A | 18.60 | None | ||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | GLY A 146VAL A 114HIS A 163HIS A 164 | 1.53A | 18.60 | NoneNoneDMS A 405 (-3.9A)None | ||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | GLY A 146VAL A 114HIS A 163HIS A 164 | 1.53A | NoneNoneP6N A 502 (-3.8A)None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | GLY A 146VAL A 114HIS A 163HIS A 164 | 1.54A | NoneNoneP6N A 502 (-3.8A)None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6yt8 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | GLY A 146VAL A 114HIS A 163HIS A 164 | 1.54A | NoneNoneDMS A 403 (-4.1A)None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6yt8 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | HIS A 41VAL A 42ASP A 187HIS A 164 | 1.42A | PK8 A 401 (-3.2A)NoneNoneNone | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6yt8 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | GLY A 146VAL A 114HIS A 163HIS A 164 | 1.53A | NoneNoneDMS A 403 (-4.1A)None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | HIS C 45GLY C 47GLY C 46VAL C 49 | 1.50A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | HIS B 45GLY B 47GLY B 46VAL B 49 | 1.47A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY B 85VAL B 82HIS B 94HIS B 86 | 1.40A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY D 85VAL D 82HIS D 94HIS D 86 | 1.39A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | HIS D 45GLY D 47GLY D 46VAL D 49 | 1.51A | NoneEDO D 206 (-4.5A)EDO D 206 ( 4.6A)EDO D 209 (-4.6A) | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | HIS B 45GLY B 47GLY B 46VAL B 49 | 1.47A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | HIS D 45GLY D 47GLY D 46VAL D 49 | 1.50A | NoneEDO D 206 (-4.5A)EDO D 206 ( 4.6A)EDO D 209 (-4.6A) | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | HIS C 45GLY C 47GLY C 46VAL C 49 | 1.50A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY E 85VAL E 82HIS E 94HIS E 86 | 1.40A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY A 85VAL A 82HIS A 94HIS A 86 | 1.42A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY C 85VAL C 82HIS C 94HIS C 86 | 1.39A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | HIS E 45GLY E 47GLY E 46VAL E 49 | 1.49A | NoneEPE E 202 (-4.3A)EPE E 202 (-3.9A)None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY B 85VAL B 82HIS B 94HIS B 86 | 1.41A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY E 85VAL E 82HIS E 94HIS E 86 | 1.40A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY A 85VAL A 82HIS A 94HIS A 86 | 1.42A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | HIS A 45GLY A 47GLY A 46VAL A 49 | 1.50A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY C 85VAL C 82HIS C 94HIS C 86 | 1.39A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY D 85VAL D 82HIS D 94HIS D 86 | 1.39A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | HIS E 45GLY E 47GLY E 46VAL E 49 | 1.49A | NoneEPE E 202 (-4.3A)EPE E 202 (-3.9A)None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | HIS A 45GLY A 47GLY A 46VAL A 49 | 1.50A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY B 85VAL B 82HIS B 94HIS B 86 | 1.40A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY C 85VAL C 82HIS C 94HIS C 86 | 1.39A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY B 85VAL B 82HIS B 94HIS B 86 | 1.40A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | HIS E 45GLY E 47GLY E 46VAL E 49 | 1.66A | NoneAPR E 201 (-4.4A)APR E 201 (-3.9A)APR E 201 (-3.7A) | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | HIS A 45GLY A 47GLY A 46VAL A 49 | 1.56A | NoneAPR A 201 (-4.1A)APR A 201 (-4.2A)APR A 201 (-3.7A) | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | HIS B 45GLY B 47GLY B 46VAL B 49 | 1.55A | NoneAPR B 201 (-3.6A)EDO B 202 (-3.9A)APR B 201 (-3.7A) | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | HIS D 45GLY D 47GLY D 46VAL D 49 | 1.65A | NoneAPR D 201 ( 4.3A)APR D 201 (-3.8A)APR D 201 (-3.7A) | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | HIS C 45GLY C 47GLY C 46VAL C 49 | 1.60A | NoneAPR C 201 (-4.3A)APR C 201 (-4.3A)APR C 201 (-3.6A) | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY E 85VAL E 82HIS E 94HIS E 86 | 1.40A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY D 85VAL D 82HIS D 94HIS D 86 | 1.41A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | HIS B 45GLY B 47GLY B 46VAL B 49 | 1.53A | NoneAPR B 201 (-3.6A)EDO B 202 (-3.9A)APR B 201 (-3.7A) | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY A 85VAL A 82HIS A 94HIS A 86 | 1.41A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY D 85VAL D 82HIS D 94HIS D 86 | 1.41A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | HIS C 45GLY C 47GLY C 46VAL C 49 | 1.62A | NoneAPR C 201 (-4.3A)APR C 201 (-4.3A)APR C 201 (-3.6A) | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | HIS A 45GLY A 47GLY A 46VAL A 49 | 1.54A | NoneAPR A 201 (-4.1A)APR A 201 (-4.2A)APR A 201 (-3.7A) | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY C 85VAL C 82HIS C 94HIS C 86 | 1.39A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY E 85VAL E 82HIS E 94HIS E 86 | 1.40A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY A 85VAL A 82HIS A 94HIS A 86 | 1.41A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | HIS A 45GLY A 47GLY A 46VAL A 49 | 1.49A | NoneMES A 201 ( 4.8A)MES A 201 ( 4.9A)None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY B 85VAL B 82HIS B 94HIS B 86 | 1.42A | NoneEDO B 203 ( 4.6A)NoneNone | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY C 85VAL C 82HIS C 94HIS C 86 | 1.42A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY A 85VAL A 82HIS A 94HIS A 86 | 1.41A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | HIS B 45GLY B 47GLY B 46VAL B 49 | 1.50A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY C 85VAL C 82HIS C 94HIS C 86 | 1.42A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | HIS C 45GLY C 47GLY C 46VAL C 49 | 1.50A | NoneMES C 201 ( 4.9A)NoneNone | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | HIS C 45GLY C 47GLY C 46VAL C 49 | 1.50A | NoneMES C 201 ( 4.9A)NoneNone | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY B 85VAL B 82HIS B 94HIS B 86 | 1.41A | NoneEDO B 203 ( 4.6A)NoneNone | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | HIS A 45GLY A 47GLY A 46VAL A 49 | 1.50A | NoneMES A 201 ( 4.8A)MES A 201 ( 4.9A)None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | HIS B 45GLY B 47GLY B 46VAL B 49 | 1.51A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | GLY A 85VAL A 82HIS A 94HIS A 86 | 1.41A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 7bqy | MAIN PROTEASE (SARS-CoV-2) | 4 / 8 | HIS A 41VAL A 42ASP A 187HIS A 164 | 1.41A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 7bqy | MAIN PROTEASE (SARS-CoV-2) | 4 / 8 | GLY A 146VAL A 114HIS A 163HIS A 164 | 1.52A | NoneNonePJE C 5 (-3.8A)None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 7bqy | MAIN PROTEASE (SARS-CoV-2) | 4 / 8 | HIS A 41VAL A 42ASP A 187HIS A 164 | 1.39A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 7bqy | MAIN PROTEASE (SARS-CoV-2) | 4 / 8 | GLY A 146VAL A 114HIS A 163HIS A 164 | 1.53A | NoneNonePJE C 5 (-3.8A)None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 7btf | NSP12 (SARS-CoV-2) | 4 / 8 | GLU A 665GLY A 683VAL A 662ASP A 623 | 1.43A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 7btf | NSP12 (SARS-CoV-2) | 4 / 8 | HIS A 599GLY A 596GLY A 597VAL A 827 | 1.41A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 7btf | NSP12 (SARS-CoV-2) | 4 / 8 | GLY A 596GLY A 597VAL A 827HIS A 599 | 1.65A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 7btf | NSP12 (SARS-CoV-2) | 4 / 8 | GLU A 665GLY A 559GLY A 503VAL A 667 | 1.32A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 7btf | NSP12 (SARS-CoV-2) | 4 / 8 | GLU A 665GLY A 683VAL A 662ASP A 623 | 1.48A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 7btf | NSP12 (SARS-CoV-2) | 4 / 8 | HIS A 599GLY A 596GLY A 597VAL A 827 | 1.42A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 7btf | NSP12 (SARS-CoV-2) | 4 / 8 | GLU A 665GLY A 559GLY A 503VAL A 667 | 1.35A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 7buy | VIRUS MAIN PROTEASE (SARS-CoV-2) | 4 / 8 | GLY A 146VAL A 114HIS A 163HIS A 164 | 1.60A | NoneNoneDMS A 402 (-3.9A)None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 7buy | VIRUS MAIN PROTEASE (SARS-CoV-2) | 4 / 8 | GLY A 146VAL A 114HIS A 163HIS A 164 | 1.58A | NoneNoneDMS A 402 (-3.9A)None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 8 | GLY A 596GLY A 597VAL A 827HIS A 599 | 1.66A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 8 | HIS A 599GLY A 596GLY A 597VAL A 827 | 1.37A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 8 | HIS A 599GLY A 596GLY A 597VAL A 827 | 1.38A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 8 | GLU A 665GLY A 679VAL A 667ASP A 684 | 1.63A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 8 | GLU A 665GLY A 679VAL A 667ASP A 684 | 1.64A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 8 | GLU A 665GLY A 678GLY A 679VAL A 667 | 1.47A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 8 | GLY A 596GLY A 597VAL A 827HIS A 599 | 1.63A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 8 | GLU A 665GLY A 678GLY A 679VAL A 667 | 1.47A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 7bv2 | NSP12 (SARS-CoV-2) | 4 / 8 | HIS A 599GLY A 596GLY A 597VAL A 827 | 1.37A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 7bv2 | NSP12 (SARS-CoV-2) | 4 / 8 | GLU A 665GLY A 678GLY A 679VAL A 667 | 1.60A | None | |||
![]() | 5F8Y_A_X6XA202_1 (GALNAC/GAL-SPECIFICLECTIN) | 7bv2 | NSP12 (SARS-CoV-2) | 4 / 8 | GLU A 665GLY A 679VAL A 667ASP A 684 | 1.57A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 7bv2 | NSP12 (SARS-CoV-2) | 4 / 8 | HIS A 599GLY A 596GLY A 597VAL A 827 | 1.35A | None | |||
![]() | 5F8Y_B_X6XB201_1 (GALNAC/GAL-SPECIFICLECTIN) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 8 | GLU A 665GLY A 678GLY A 679VAL A 667ASP A 684 | 1.65A | None |